Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the 8th RNA-Targeted Drug Discovery & Development Summit.

Adam Buckle - Arrayjet, 8th RNA-Targeted Drug Discovery & Development Summit

Adam Buckle

Chief Scientific Officer

Arrayjet

Akihiro Furukawa

Director, Research & Technology Search & Evaluation, Global Business Development

Daiichi Sankyo

Amanda Hargrove - University of Toronto, 8th RNA-Targeted Drug Discovery & Development Summit

Amanda Hargrove

Professor of Chemistry

University of Toronto

Atsushi Shiomi -NS Pharma , 8th RNA-Targeted Drug Discovery & Development Summit

Atsushi Shiomi

Director of Innovation Research Partnering

NS Pharma, Inc.

Balajee Somalinga - CHDI Foundation, 8th RNA-Targeted Drug Discovery & Development Summit

Balajee Somalinga

Director - Ribonucleic Acid Biology

CHDI Foundation

Brittany Morgan - University of Notre Dame, 8th RNA-Targeted Drug Discovery & Development Summit

Brittany Morgan

Assistant Professor

University of Notre Dame

Chris Odonnell - 8th RNA-Targeted Drug Discovery Summit

Christopher O’Donnell

Partner & Vice President of Worldwide Business Development

Pfizer Ventures

Chris Trotta - PTC Therapeutics, 8th RNA-Targeted Drug Discovery & Development Summit

Christopher trotta

svp

PTC Therapeutics

David Sparkman-Yager -Wayfinder Bio, 8th RNA-Targeted Drug Discovery & Development Summit

David Sparkman-Yager

Chief Technology Officer

Wayfinder Biosciences

Domi Stickens - 8th RNA-Targeted Drug Discovery Summit

Domi Stickens

Vice President of Discovery & Translational Sciences

Arrakis Therapeutics Inc.

Dominic Reynolds - Remix Therapeutics, 8th RNA-Targeted Drug Discovery & Development Summit

Dominic Reynolds

Chief Scientific Officer

Remix Therapeutics

Elena Diez Cecilia - Johnson & Johnson, 8th RNA-Targeted Drug Discovery & Development Summit

Elena Diez Cecilia

Senior Director of External Innovation, DPDS

Johnson & Johnson

Ella Czarina Morishita - Veritas In Silico, 8th RNA-Targeted Drug Discovery & Development Summit

Ella Morishita

CSO

Veritas In Silico Inc.

Jeffrey Kieft - New York Structural Biology Center, 8th RNA-Targeted Drug Discovery & Development Summit

Jeffrey Kieft

Executive Director

New York Structural Biology Center

Jennifer Petter - Arrakis Therapeutics, 8th RNA-Targeted Drug Discovery & Development Summit

Jennifer Petter

Chief Scientific Officer

Arrakis Therapeutics Inc.

Jerry McMahon - Storm Therapeutics, 8th RNA-Targeted Drug Discovery & Development Summit

Jerry McMahon

Chief Executive Officer & President

STORM Therapeutics Ltd.

Jimin Hwang -Pyle Lab at Yale University, 8th RNA-Targeted Drug Discovery & Development Summit

Jimin Hwang

Researcher

Pyle Lab at Yale University

Karen Wu - Lucerna, 8th RNA-Targeted Drug Discovery & Development Summit

Karen Wu

President & Co-Founder

Lucerna, Inc.

Kevin Weeks - UNC at Chapel Hill, 8th RNA-Targeted Drug Discovery & Development Summit

Kevin Weeks

Distinguished Professor of Chemistry and Founder

UNC at Chapel Hill

Ken Hsu - University of Texas at Austin, 8th RNA-Targeted Drug Discovery & Development Summit

Ku-Lung (Ken) Hsu

Associate Professor - Chemistry

The University of Texas at Austin

Matt Woll - PTC Therapeutics, 8th RNA-Targeted Drug Discovery & Development Summit

Matt Woll

SVP

PTC Therapeutics

Nikolai Naryshkin - Ribonaut Therapeutics, 8th RNA-Targeted Drug Discovery & Development Summit

Nikolai Naryshkin

Chief Scientific Officer

Ribonaut Therapeutics

Paige Diamond - Interdict Bio, 8th RNA-Targeted Drug Discovery & Development Summit

Paige Diamond

Senior Investigator

Interdict Bio

Peng Yue - ReviR Therapeutics, 8th RNA-Targeted Drug Discovery & Development Summit

Peng Yue

Co-Founder & Chief Executive Officer

ReviR Therapeutics

Perla Bracci - Astex Pharmaceuticals, 8th RNA-Targeted Drug Discovery & Development Summit

Perla Breccia

Senior Director - Chemistry

Astex Pharmaceuticals

Shunichi Kashida - xFOREST Therapeutics , 8th RNA-Targeted Drug Discovery & Development Summit

Shunichi Kashida

Co-Founder, Representative Director, President & Chief Executive Officer

xFOREST Therapeutics Co. Ltd.

Stephan Eismann - Atomic AI, 8th RNA-Targeted Drug Discovery & Development Summit

Stephan Eismann

Head of Machine Learning

Atomic AI

Thomas Wynn - Rgenta Therapeutics, 8th RNA-Targeted Drug Discovery & Development Summit

Thomas Wynn

Director - Medicinal Chemistry

Rgenta Therapeutics Inc.

Yann Foricher - 8th RNA-Targeted Drug Discovery Summit

Yann Foricher

Head of Small Molecules Medicinal Chemistry

Sanofi

Yaqiang Wang -Medical College of Wisconsin, 8th RNA-Targeted Drug Discovery & Development Summit

Yaqiang Wang

Assistant Professor

Medical College of Wisconsin

Full Event Guide
Register
Partner